Abstract
Binding interaction between ligand and G-protein coupled receptor plays an important role in the several steps of exertion of therapeutic effect by a drug and has become increasingly interesting to pharmacists, chemists, biologists and companies. α1-Adrenoceptor (α1-AR) was purified from cell line which stably expressed α1-AR and evenly immobilized on the surface of macroporous silica gel to prepare a novel stationary phase for investigating the interaction between drug and receptor. Control drugs of α1-AR including phentolamine, terazosin and urapidil were used to characterize the retention properties of the stationary phase containing the receptor. Further work was performed to calculate the binding sites and association constant of prazosin binding to the immobilized receptor. The results presented a value of 4.55 × 10−7 M−1 for binding sites and of 2.2 × 104 M for the association constant during the interaction between prazosin and α1-AR. The proposed affinity method was stable at least in seven consecutive days, as well as had the primary bioactivities of recognizing and binding the ligand, providing an alternative for representing the interaction between drug and functional protein.
References
Harris ESJ, Erickson SD, Tolopko AN, Cao SG, Cryvcroft JA, Scholten R, Fu YL, Wang WQ, Liu Y, Zhao ZZ, Clardy J, Shamu CE, Eisenberg DM (2011) J Ethnopharmacol 135:590–593. doi:10.1016/j.jep.2011.03.029
Zhou XZ, Peng YH, Liu BY (2010) J Biomed Inform 43:650–660. doi:10.1016/j.jbi.2010.01.002
Gu JY, Zhang H, Chen LR, Xu S, Yuan G, Xu XJ (2011) Comput Biol Chem 35:293–297. doi:10.1016/j.compbiolchem.2011.07.003
Xu F, Peng DY, Tao CL, Yin DK, Kou JP, Zhu DN, Yu BY (2011) Phytomedicine 18:1130–1136. doi:10.1016/j.phymed.2011.05.002
Xu XJ (2006) Drug Discov Today: Technol 3:247–253. doi:10.1016/j.ddtec.2006.09.008
Zhang Y, Hu CX, Liu CP, Li HF, Wang JS, Yuan KL, Tang JW, Xu GW (2007) J Pharma Biomed 43:151–157. doi:10.1016/j.jpha.2006.06.033
Huang XD, Kong L, L X, Chen XG, Guo M, Zou HF (2004) J Chromatogr B 812: 71–84. doi:10.1016/j.jchromb.2004.06.046
Medina-Franco JL, López-Vallejo F, Kuck D, Lyko F (2011) Mol Divers 15:293–304. doi:10.1007/s11030-010-9262-5
Fruh V, Zhou YP, Chen D, Loch C, Eiso AB, Grinkova YN, Verheij H, Sligar SG, Bushweller JH, Siegal G (2010) Chem Biol 17:881–891. doi:10.1016/j.chembiol.2010.06.011
Han LY, Wang YL, Bryant SH (2009) Bioinformatics 25:2251–2255. doi:10.1093/bioinformatics/btp380
Sutherland JJ, Low J, Blosser W, Dowless M, Engler TA, Stancato LF (2011) Mol Cancer Ther 10:242–254. doi:10.1158/1535-7163.MCT-10.0720
Gandhari Mk, Frazier CR, Hartenstein JS, Cloix JF, Bernier M, Wainer IW (2010) Mol Cell Endocrinol 315:314–326. doi:10.1016/j.mce.2009.10.001
Jozwiak K, Yiu-Ho Woo A, Tanga MJ, Toll L, Jimenez L, Kozocas JA, Plazinska A, Xiao RP, Wainer IW (2010) Biochem Pharmacol 79:1610–1615. doi:10.1016/j.bcp.2010.035
Jozwiak K, Yiu-Ho Woo A, Tanga MJ, Toll L, Jimenez L, Kozocas JA, Plazinska A, Xiao RP, Wainer IW (2010) Bioorg Med Chem 18:728–736. doi:10.1016/j.bmc.2009.11.062
Zhang BY, Palcic MM, Schriemer DC, Alvarez-Manilla G, Pierce Michael, Hindsgaul O (2001) Anal Biochem 229: 173–182. doi:10.1006/abio.2001.5417
Chan NWC, Lewis DF, Rosner PJ, Kelly MA, Schriemer DC (2003) Anal Biochem 319:1–12. doi:10.1016/S0003-2697(03)00193-3
Long I, Andersson P, Seifert E, Lundstedt T (2004) Chemom Intell Lab 73:95–104. doi:10.1016/j.chemolab.2003.12.008
Panetta R, Greenwood MT (2008) Drug Discov Today 13:1059–1066. doi:10.1016/j.drudis.2008.09.002
MacDougall IJA, Griffith R (2006) J Mol Graph Model 25:146–157. doi:10.1016/j.jmgm.2005.12.001
Dzimiri N, Moorji A, Kumar M, Bakr S, Kumar N, Almotrefi AA, Halees Z (1996) Gen Pharmacol 27:539–543
Orallo F, Garcia-Ferreiro T, Enguix MJ, Tristan H, Masaguer C, Ravina E, Cadavid I, Loza MI (2003) Vasc Pharmacol 40:97–108. doi:10.1016/S1537-1891(02)00337-3
Zheng XH, Zhao XF, Yang R, Wang SX, Wei YM, Zheng JB (2008) Chin Sci Bull 53:842–847. doi:10.1007/s11434-007-0510-8
Zhao XF, Zheng XH, Wei YM, Bian LJ, Wang SX, Zheng JB, Zhang YY, Li ZJ, Zang WJ (2009) J Chromatogr B 877:911–918. doi:10.1016/j.jchromb.2009.02.031
Zhao XF, Nan YF, Xiao CN, Zheng JB, Zheng XH, Wei YM, Zhang YY (2010) J Chromatogr B 878:2029–2034. doi:10.1016/j.jchromb.2010.05.040
Wang Y, Yuan BX, Deng XL, He LC, Zhang YY, Han QD (2005) Anal Biochem 339:198–205. doi:10.1016/j.ab.2005.01.004
Graham RM, Hess HJ, Homcy CJ (1982) J Biol Chem 257:15174–15181
Acknowledgments
Financial support was kindly provided from the National Natural Sciences Foundation of China (Nos. 21005060), the Chinese Ministry of Education (No. 20106101110001), Technology Support Plan Project (No. 2008BAI51B01) the Department of Education of the Shaanxi Province (No. 11JK0661), and the Key Innovative Project (2010ZDKG-46) of Science and Technology from Shaanxi Province.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhao, X., Lu, H., Huang, J. et al. Binding Interaction Between Prazosin and Immobilized Receptor by Frontal Analysis. Chromatographia 75, 411–415 (2012). https://doi.org/10.1007/s10337-012-2198-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-012-2198-4